A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny ...
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...
7h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...
Every year, several people across India are hit with the devastating news of a cancer diagnosis, leaving them grappling with uncertainty and emotional turmoil .
Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...
GlobalData on MSN
USPTO grants patent to Genprex’s Reqorsa gene therapy
The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback